PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
16130505-4	2005	We examined changes in dermal thickness and appearance of skin disorders in five months old MRL/lpr mice by oral treatment with etretinate, a retinoic acid derivative.	Etretinate	128-138	Fas (TNF receptor superfamily member 6)	Mus musculus	96-99	
16130505-5	2005	Etretinate treated MRL/lpr mice did not have skin lesions or dermatopathological characteristics including an increase in cells infiltrating the dermis.	Etretinate	0-10	Fas (TNF receptor superfamily member 6)	Mus musculus	23-26	
16130505-6	2005	The mean dermal thickness of MRL/lpr and MRL/n mice treated with etretinate decreased significantly and apoptotic cells density in the dermis of MRL/lpr mice with etretinate was significantly higher compared with the control group (P < 0.05) although MRL/lpr mice have a defect within the Fas antigen.	Etretinate	65-75	Fas (TNF receptor superfamily member 6)	Mus musculus	149-152	
16130505-6	2005	The mean dermal thickness of MRL/lpr and MRL/n mice treated with etretinate decreased significantly and apoptotic cells density in the dermis of MRL/lpr mice with etretinate was significantly higher compared with the control group (P < 0.05) although MRL/lpr mice have a defect within the Fas antigen.	Etretinate	65-75	Fas (TNF receptor superfamily member 6)	Mus musculus	149-152	
16130505-6	2005	The mean dermal thickness of MRL/lpr and MRL/n mice treated with etretinate decreased significantly and apoptotic cells density in the dermis of MRL/lpr mice with etretinate was significantly higher compared with the control group (P < 0.05) although MRL/lpr mice have a defect within the Fas antigen.	Etretinate	65-75	Fas (TNF receptor superfamily member 6)	Mus musculus	292-303	
16130505-6	2005	The mean dermal thickness of MRL/lpr and MRL/n mice treated with etretinate decreased significantly and apoptotic cells density in the dermis of MRL/lpr mice with etretinate was significantly higher compared with the control group (P < 0.05) although MRL/lpr mice have a defect within the Fas antigen.	Etretinate	163-173	Fas (TNF receptor superfamily member 6)	Mus musculus	149-152	
16130505-6	2005	The mean dermal thickness of MRL/lpr and MRL/n mice treated with etretinate decreased significantly and apoptotic cells density in the dermis of MRL/lpr mice with etretinate was significantly higher compared with the control group (P < 0.05) although MRL/lpr mice have a defect within the Fas antigen.	Etretinate	163-173	Fas (TNF receptor superfamily member 6)	Mus musculus	149-152	
16130505-6	2005	The mean dermal thickness of MRL/lpr and MRL/n mice treated with etretinate decreased significantly and apoptotic cells density in the dermis of MRL/lpr mice with etretinate was significantly higher compared with the control group (P < 0.05) although MRL/lpr mice have a defect within the Fas antigen.	Etretinate	163-173	Fas (TNF receptor superfamily member 6)	Mus musculus	292-303